Assenagon Asset Management S.A. Fate Therapeutics Inc Transaction History

Assenagon Asset Management S.A.

  • $47.8 Billion
  • Q3 2024

A detailed history of Assenagon Asset Management S.A. transactions in Fate Therapeutics Inc stock. As of the latest transaction made, Assenagon Asset Management S.A. holds 2,434,198 shares of FATE stock, worth $4.09 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
2,434,198
Previous 2,574,703 5.46%
Holding current value
$4.09 Million
Previous $8.45 Million 0.88%
% of portfolio
0.02%
Previous 0.02%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 23, 2024
SELL
$3.12 - $5.57 $438,375 - $782,612
-140,505 Reduced 5.46%
2,434,198 $8.52 Million
Q2 2024

Jul 18, 2024
BUY
$3.26 - $7.08 $86,060 - $186,904
26,399 Added 1.04%
2,574,703 $8.45 Million
Q1 2024

Apr 24, 2024
BUY
$3.54 - $8.35 $8.44 Million - $19.9 Million
2,385,207 Added 1462.45%
2,548,304 $18.7 Million
Q4 2023

Jan 17, 2024
SELL
$1.65 - $3.94 $359,106 - $857,501
-217,640 Reduced 57.16%
163,097 $609,000
Q3 2023

Nov 06, 2023
BUY
$2.02 - $5.04 $567,407 - $1.42 Million
280,895 Added 281.34%
380,737 $807,000
Q2 2023

Jul 25, 2023
BUY
$4.76 - $6.59 $475,247 - $657,958
99,842 New
99,842 $475,000
Q3 2022

Oct 27, 2022
SELL
$21.04 - $36.06 $441 - $757
-21 Reduced 0.14%
14,583 $327,000
Q2 2022

Jul 27, 2022
SELL
$17.78 - $42.39 $106 - $254
-6 Reduced 0.04%
14,604 $362,000
Q1 2022

Apr 25, 2022
SELL
$29.67 - $60.28 $148 - $301
-5 Reduced 0.03%
14,610 $566,000
Q4 2021

Feb 01, 2022
SELL
$47.84 - $64.34 $5.26 Million - $7.07 Million
-109,893 Reduced 88.26%
14,615 $855,000
Q3 2021

Oct 19, 2021
SELL
$59.27 - $95.73 $17.4 Million - $28 Million
-292,850 Reduced 70.17%
124,508 $7.38 Million
Q2 2021

Jul 15, 2021
BUY
$67.25 - $92.52 $28.1 Million - $38.6 Million
417,358 New
417,358 $36.2 Million
Q1 2021

Apr 26, 2021
SELL
$72.16 - $117.4 $1.83 Million - $2.97 Million
-25,323 Closed
0 $0
Q4 2020

Feb 01, 2021
SELL
$38.09 - $100.95 $2.2 Million - $5.83 Million
-57,776 Reduced 69.53%
25,323 $2.3 Million
Q3 2020

Oct 07, 2020
BUY
$30.41 - $40.5 $1.3 Million - $1.73 Million
42,721 Added 105.8%
83,099 $3.32 Million
Q2 2020

Jul 21, 2020
BUY
$20.21 - $35.23 $816,039 - $1.42 Million
40,378 New
40,378 $1.39 Million

Others Institutions Holding FATE

# of Institutions
175
Shares Held
115M
Call Options Held
53.7K
Put Options Held
9K
View Full List

About FATE THERAPEUTICS INC

FATE Quotes by TradingView
  • Ticker FATE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 97,000,304
  • Market Cap $163M
  • Description
  • Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. Its NK- and T-cell immuno-oncology programs under development include FT516 for the treatment of acute myeloid leukemia (AML) B-cell lymphoma, and advanced solid tumor; FT596 to treat B-cell...
More about FATE
Track This Portfolio

Track Assenagon Asset Management S.A. Portfolio

Follow Assenagon Asset Management S.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Assenagon Asset Management S.A., based on Form 13F filings with the SEC.

News

Stay updated on Assenagon Asset Management S.A. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email